These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 25425433)

  • 1. Antibiotic susceptibility of Clostridium difficile is similar worldwide over two decades despite widespread use of broad-spectrum antibiotics: an analysis done at the University Hospital of Zurich.
    Büchler AC; Rampini SK; Stelling S; Ledergerber B; Peter S; Schweiger A; Ruef C; Zbinden R; Speck RF
    BMC Infect Dis; 2014 Nov; 14():607. PubMed ID: 25425433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antimicrobial susceptibility of Clostridium difficile clinical isolates collected from 2001 to 2007 in a French university hospital].
    Cattoir V; Ould-Hocine ZF; Legrand P
    Pathol Biol (Paris); 2008; 56(7-8):407-11. PubMed ID: 18845403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Survey of susceptibility of clinical Clostridium diffiicile strains isolated from patients hospitalised in different departments of paediatric hospital to antimicrobial agents].
    Wultańska D; Obuch-Woszczatyński P; Pituch H; Luczak M
    Med Dosw Mikrobiol; 2007; 59(2):161-8. PubMed ID: 17929413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance of Antibiotic Resistance among Hospital- and Community-Acquired Toxigenic Clostridium difficile Isolates over 5-Year Period in Kuwait.
    Jamal WY; Rotimi VO
    PLoS One; 2016; 11(8):e0161411. PubMed ID: 27536994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter-based study on epidemiology, antibiotic susceptibility and risk factors of toxigenic Clostridium difficile in hospitalized patients in southwestern Iran.
    Sedigh Ebrahim-Saraie H; Heidari H; Amanati A; Bazargani A; Alireza Taghavi S; Nikokar I; Kalantar K; Motamedifar M
    Infez Med; 2018 Dec; 26(4):308-315. PubMed ID: 30555133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridium difficile infections in a Shanghai hospital: antimicrobial resistance, toxin profiles and ribotypes.
    Huang H; Wu S; Wang M; Zhang Y; Fang H; Palmgren AC; Weintraub A; Nord CE
    Int J Antimicrob Agents; 2009 Apr; 33(4):339-42. PubMed ID: 19097757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility of Clostridium difficile clinical isolates from a multi-institutional outbreak in Southern Québec, Canada.
    Bourgault AM; Lamothe F; Loo VG; Poirier L;
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3473-5. PubMed ID: 17005836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predominance and high antibiotic resistance of the emerging Clostridium difficile genotypes NAPCR1 and NAP9 in a Costa Rican hospital over a 2-year period without outbreaks.
    López-Ureña D; Quesada-Gómez C; Montoya-Ramírez M; del Mar Gamboa-Coronado M; Somogyi T; Rodríguez C; Rodríguez-Cavallini E
    Emerg Microbes Infect; 2016 May; 5(5):e42. PubMed ID: 27165560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence and control of fluoroquinolone-resistant, toxin A-negative, toxin B-positive Clostridium difficile.
    Drudy D; Harnedy N; Fanning S; Hannan M; Kyne L
    Infect Control Hosp Epidemiol; 2007 Aug; 28(8):932-40. PubMed ID: 17620240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two Clusters of Fluoroquinolone and Clindamycin-Resistant Clostridium difficile PCR Ribotype 001 Strain Recognized by Capillary Electrophoresis Ribotyping and Multilocus Variable Tandem Repeat Analysis.
    Nyc O; Tejkalova R; Kriz Z; Ruzicka F; Kubicek L; Matejkova J; Kuijper E; Krutova M
    Microb Drug Resist; 2017 Jul; 23(5):609-615. PubMed ID: 27860531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility of polymerase chain reaction ribotypes of Clostridium difficile commonly isolated from symptomatic hospital patients in the UK.
    John R; Brazier JS
    J Hosp Infect; 2005 Sep; 61(1):11-4. PubMed ID: 16002183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epidemiological study of Clostridium difficile strains isolated in Jean-Verdier-René-Muret hospitals from 2001 to 2007].
    Poilane I; Fantinato C; Cruaud P; Collignon A
    Pathol Biol (Paris); 2008; 56(7-8):412-6. PubMed ID: 18842360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of an outbreak of diarrhoea in a vascular surgery unit caused by a high-level clindamycin-resistant Clostridium difficile PCR ribotype 106.
    Ratnayake L; McEwen J; Henderson N; Nathwani D; Phillips G; Brown D; Coia J
    J Hosp Infect; 2011 Nov; 79(3):242-7. PubMed ID: 21864938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Typing and susceptibility of bacterial isolates from the fidaxomicin (OPT-80) phase II study for C. difficile infection.
    Citron DM; Babakhani F; Goldstein EJ; Nagaro K; Sambol S; Sears P; Shue YK; Gerding DN
    Anaerobe; 2009 Dec; 15(6):234-6. PubMed ID: 19755166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of increased colonization with vancomycin-resistant enterococci during preferential use of vancomycin for treatment during an outbreak of healthcare-associated Clostridium difficile infection.
    Miller M; Bernard L; Thompson M; Grima D; Pepin J
    Infect Control Hosp Epidemiol; 2010 Jul; 31(7):710-5. PubMed ID: 20518636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in sensitivity patterns to selected antibiotics in Clostridium difficile in geriatric in-patients over an 18-month period.
    Drummond LJ; McCoubrey J; Smith DGE; Starr JM; Poxton IR
    J Med Microbiol; 2003 Mar; 52(Pt 3):259-263. PubMed ID: 12621092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial activity of LFF571 and three treatment agents against Clostridium difficile isolates collected for a pan-European survey in 2008: clinical and therapeutic implications.
    Debast SB; Bauer MP; Sanders IM; Wilcox MH; Kuijper EJ;
    J Antimicrob Chemother; 2013 Jun; 68(6):1305-11. PubMed ID: 23420839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of antimicrobial susceptibility among Clostridium difficile isolated from an integrated human and swine population in Texas.
    Norman KN; Scott HM; Harvey RB; Norby B; Hume ME
    Foodborne Pathog Dis; 2014 Apr; 11(4):257-64. PubMed ID: 24320797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of Clostridium difficile infections in a tertiary-care hospital in Korea.
    Kim J; Kang JO; Kim H; Seo MR; Choi TY; Pai H; Kuijper EJ; Sanders I; Fawley W
    Clin Microbiol Infect; 2013 Jun; 19(6):521-7. PubMed ID: 22712697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Clostridium difficile infection in a French university hospital.
    Khanafer N; Blais L; Barbut F; Hirschel B; Vanhems P
    Scand J Gastroenterol; 2015; 50(10):1253-60. PubMed ID: 25877477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.